Nicotinamide Riboside (NR) is a naturally occurring NAD+ precursor and one of the most clinically validated anti-aging ingredients on the market. It is the active molecule behind Tru Niagen® (ChromaDex), with extensive patent and clinical backing.
A landmark 2026 Nature Metabolism study confirmed NR delivers the highest blood NAD+ elevation among tested boosters (+49.4 µM). Uniquely, NR's conversion pathway goes through the gut microbiome—promoting beneficial bacteria and short-chain fatty acid (SCFA) production for a dual “systemic NAD+ + gut health” benefit.
NR has good baseline oral absorption, but liposomal encapsulation takes its performance further. By protecting NR through the GI tract and improving cellular delivery, liposomal NR delivers superior bioavailability and formulation versatility.
Key advantages of liposomal NR:
A phospholipid bilayer vesicle engineered at nanoscale to protect NR and enhance cellular uptake for efficient NAD+ biosynthesis.
Non-GMO sunflower lecithin
Double-layer membrane mimicking natural cell structure. Hydrophilic heads face outward and inward; hydrophobic tails form the core barrier.
Acid-resistant protection
The lipid tail core blocks gastric acid and enzymatic degradation. NR — normally unstable in the GI tract — stays intact through stomach transit, preserving its NAD+ precursor activity.
≥98% purity nicotinamide riboside
Water-soluble NR (a pyridine-nucleoside and key NAD+ precursor) encapsulated in the inner aqueous compartment. Protected from degradation until membrane fusion releases it intracellularly.
Enhanced cellular uptake
Liposome bilayer fuses with cell membrane, releasing NR directly into the cytoplasm. NR is phosphorylated by NRK enzymes to NMN, then rapidly converted to NAD+ — a proven pathway for boosting cellular NAD+ levels.
Five-stage GMP manufacturing process ensuring uniform particle size and high encapsulation efficiency.
Phospholipids dissolved in organic solvent, dried to a thin film under vacuum. NR aqueous solution added for hydration.
Probe sonication breaks down multi-lamellar vesicles into uniform small unilamellar vesicles (SUVs), 80-200 nm.
High-pressure homogenization at 20,000 psi ensures narrow particle size distribution (PDI < 0.2) and stability.
Sterile filtration (0.22 µm), encapsulation efficiency testing (≥92%), NR purity verification (HPLC), and microbial screening.
Freeze-drying for powder format or aseptic filling for liquid. Full COA issued with every batch.
Research-backed benefits of NR supplementation with the most clinical evidence among NAD+ precursors.
Elevates NAD+ and activates sirtuin longevity proteins for systemic anti-aging effects.
Supports mitochondrial function and ATP production for sustained vitality.
Provides cognitive and neural support through elevated neuronal NAD+ levels.
Promotes beneficial bacteria growth and short-chain fatty acid production.
NR's distinctive advantage is its gut microbiome-mediated conversion pathway. Unlike NMN (direct NMNAT conversion) or NAD+ (direct supplementation), NR is substantially converted by gut bacteria to nicotinic acid (NA) before systemic NAD+ synthesis via the Preiss–Handler pathway.
This creates a unique dual-benefit positioning: systemic NAD+ elevation + gut health promotion (microbiome growth and SCFA production). NR also pairs exceptionally well with resveratrol for synergistic sirtuin activation—a classic anti-aging combination.
Patent Note: Core NR patents held by ChromaDex (Tru Niagen®). Evaluate licensing before own-brand development.
Evidence-based guidance for NR product development and patent considerations.
| Route | Typical Dosage | Notes |
|---|---|---|
| Oral (Standard) | 300 mg/day | Tru Niagen® reference dose |
| Oral (Liposomal) | 300 mg/day | Studies up to 1 g/day well tolerated |
No unified regulatory dosage. Above ranges reflect common supplement intervals. Not medical advice.
Common questions about liposomal NR.
Request samples, review our technical documentation, or speak with a formulation specialist about integrating liposomal NAD+ into your product line.